What is Biote Corp.'s deferred revenue?

Biote Corp. (BTMD) reported deferred revenue of -$344K in Q1 2026.

How has Biote Corp.'s deferred revenue changed year-over-year?

Biote Corp.'s deferred revenue decreased by 1128.6% year-over-year, from -$28K to -$344K.

What is the long-term trend for Biote Corp.'s deferred revenue?

Over 2 years (2022 to 2025), Biote Corp.'s deferred revenue has grown at a 2.1% compound annual growth rate (CAGR), from $384K to -$400K.

Biote Corp. BTMD Deferred Revenue

Deferred Revenue at other companies

NAG

Niagen Bioscience, Inc. Common StockNAGE

——

Other financials

Income statement

See full

Revenue$44.9M-8.3%

Gross profit$31.0M-14.9%

Operating income$3.2M-67.3%

Net income$2.3M-83.4%

EPS (diluted)$0.06-83.8%

Balance sheet

See full

Cash & equivalents$5.3M-87.2%

Total debt$103.4M-5.5%

Total equity-$56.1M+37.7%

Total assets$89.0M-27.8%

Cash flow

See full

Operating cash flow$3.9M-39.7%

CapEx$362.0K-77.8%

Free cash flow$3.5M-26.8%

Valuation

See full

Market cap$57.33M-51.2%

Enterprise value$155.43M-26.5%

P/E3.7×-0.1×

P/S0.3×-0.3×

Profitability

See full

Gross margin70.1%-1.2pp

Operating margin15.4%-0.1pp

Net margin8.3%-2.3pp

FCF margin15.3%-3.2pp

Returns & leverage

See full

Return on equity-21.4%—

Debt / equity9.1×—

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biote Corp.'s deferred revenue?: Biote Corp. (BTMD) reported deferred revenue of -$344K in Q1 2026.
How has Biote Corp.'s deferred revenue changed year-over-year?: Biote Corp.'s deferred revenue decreased by 1128.6% year-over-year, from -$28K to -$344K.
What is the long-term trend for Biote Corp.'s deferred revenue?: Over 2 years (2022 to 2025), Biote Corp.'s deferred revenue has grown at a 2.1% compound annual growth rate (CAGR), from $384K to -$400K.